BRAVESST2
Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc.
University of Florida
Chimeric Therapeutics
National Institutes of Health Clinical Center (CC)
Tanabe Pharma America, Inc.
Perspective Therapeutics
BioXcel Therapeutics Inc
Hutchmed
National Health Research Institutes, Taiwan
Turning Point Therapeutics, Inc.
PharmaMar
Hoffmann-La Roche
University Hospital, Basel, Switzerland
AHS Cancer Control Alberta
Hutchmed
Imperial College London
Peking Union Medical College Hospital
Melanoma and Skin Cancer Trials Limited
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Teclison Ltd.
National Health Research Institutes, Taiwan
Medical University Innsbruck
Ipsen
Institut Bergonié
Peking Union Medical College Hospital
University of Iowa
Xiangya Hospital of Central South University
University of California, San Francisco
University of Maryland, Baltimore
Ipsen
King Faisal Specialist Hospital & Research Center
Xiangya Hospital of Central South University
Insel Gruppe AG, University Hospital Bern
Molecular Insight Pharmaceuticals, Inc.
Ochsner Health System
Guangdong Provincial People's Hospital